162 related articles for article (PubMed ID: 37649552)
1. CD56
Lee M; Bell CJM; Rubio Garcia A; Godfrey L; Pekalski M; Wicker LS; Todd JA; Ferreira RC
Discov Immunol; 2023; 2(1):kyad012. PubMed ID: 37649552
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxicity of CD56(bright) NK cells towards autologous activated CD4+ T cells is mediated through NKG2D, LFA-1 and TRAIL and dampened via CD94/NKG2A.
Nielsen N; Ødum N; Ursø B; Lanier LL; Spee P
PLoS One; 2012; 7(2):e31959. PubMed ID: 22384114
[TBL] [Abstract][Full Text] [Related]
3. NK cells of HIV-1-infected patients with poor CD4
Giuliani E; Vassena L; Di Cesare S; Malagnino V; Desimio MG; Andreoni M; Barnaba V; Doria M
Immunol Lett; 2017 Oct; 190():185-193. PubMed ID: 28826739
[TBL] [Abstract][Full Text] [Related]
4. High Dose Intravenous IgG Therapy Modulates Multiple NK Cell and T Cell Functions in Patients With Immune Dysregulation.
McAlpine SM; Roberts SE; Heath JJ; Käsermann F; Issekutz AC; Issekutz TB; Derfalvi B
Front Immunol; 2021; 12():660506. PubMed ID: 34093549
[TBL] [Abstract][Full Text] [Related]
5. CD56
Vujanovic L; Chuckran C; Lin Y; Ding F; Sander CA; Santos PM; Lohr J; Mashadi-Hossein A; Warren S; White A; Huang A; Kirkwood JM; Butterfield LH
Front Immunol; 2019; 10():14. PubMed ID: 30761123
[TBL] [Abstract][Full Text] [Related]
6. CD56+bright and CD56+dim natural killer cells in patients with chronic myelogenous leukemia progressively decrease in number, respond less to stimuli that recruit clonogenic natural killer cells, and exhibit decreased proliferation on a per cell basis.
Pierson BA; Miller JS
Blood; 1996 Sep; 88(6):2279-87. PubMed ID: 8822949
[TBL] [Abstract][Full Text] [Related]
7. Role of chemokines in the biology of natural killer cells.
Maghazachi AA
Curr Top Microbiol Immunol; 2010; 341():37-58. PubMed ID: 20369317
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Impact of Daclizumab Beta on Circulating Natural Killer Cells by Mass Cytometry.
Ranganath T; Simpson LJ; Ferreira AM; Seiler C; Vendrame E; Zhao N; Fontenot JD; Holmes S; Blish CA
Front Immunol; 2020; 11():714. PubMed ID: 32391016
[TBL] [Abstract][Full Text] [Related]
9. Blood CD4
Liao J; Li Y; Li X; Su X; Peng J; Xiao N; Fan X; Chen H; Lu G; Lin G; Cheng L; Gong F
Int Immunopharmacol; 2022 Sep; 110():108960. PubMed ID: 35759810
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-21 differentially affects human natural killer cell subsets.
Wendt K; Wilk E; Buyny S; Schmidt RE; Jacobs R
Immunology; 2007 Dec; 122(4):486-95. PubMed ID: 17635612
[TBL] [Abstract][Full Text] [Related]
11. CD56
Wang H; Zeng Y; Zhang M; Ma H; Xu B; Jiang H; Wang J; Li G
Hum Immunol; 2019 Oct; 80(10):871-877. PubMed ID: 31326139
[TBL] [Abstract][Full Text] [Related]
12. Oncolytic virus treatment differentially affects the CD56
Wantoch M; Wilson EB; Droop AP; Phillips SL; Coffey M; El-Sherbiny YM; Holmes TD; Melcher AA; Wetherill LF; Cook GP
Immunology; 2022 May; 166(1):104-120. PubMed ID: 35156714
[TBL] [Abstract][Full Text] [Related]
13. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-1beta costimulates interferon-gamma production by human natural killer cells.
Cooper MA; Fehniger TA; Ponnappan A; Mehta V; Wewers MD; Caligiuri MA
Eur J Immunol; 2001 Mar; 31(3):792-801. PubMed ID: 11241284
[TBL] [Abstract][Full Text] [Related]
15. Human Circulating and Tissue-Resident CD56(bright) Natural Killer Cell Populations.
Melsen JE; Lugthart G; Lankester AC; Schilham MW
Front Immunol; 2016; 7():262. PubMed ID: 27446091
[TBL] [Abstract][Full Text] [Related]
16. CD56brightCD16- NK Cells Produce Adenosine through a CD38-Mediated Pathway and Act as Regulatory Cells Inhibiting Autologous CD4+ T Cell Proliferation.
Morandi F; Horenstein AL; Chillemi A; Quarona V; Chiesa S; Imperatori A; Zanellato S; Mortara L; Gattorno M; Pistoia V; Malavasi F
J Immunol; 2015 Aug; 195(3):965-72. PubMed ID: 26091716
[TBL] [Abstract][Full Text] [Related]
17. Increased oxidative stress contributes to impaired peripheral CD56
Lu Z; Tian Y; Bai Z; Liu J; Zhang Y; Qi J; Jin M; Zhu J; Li X
Arthritis Res Ther; 2022 Feb; 24(1):48. PubMed ID: 35172900
[TBL] [Abstract][Full Text] [Related]
18. Human CD56
Amand M; Iserentant G; Poli A; Sleiman M; Fievez V; Sanchez IP; Sauvageot N; Michel T; Aouali N; Janji B; Trujillo-Vargas CM; Seguin-Devaux C; Zimmer J
Front Immunol; 2017; 8():699. PubMed ID: 28674534
[TBL] [Abstract][Full Text] [Related]
19. CD56brightCD16+ NK cells: a functional intermediate stage of NK cell differentiation.
Béziat V; Duffy D; Quoc SN; Le Garff-Tavernier M; Decocq J; Combadière B; Debré P; Vieillard V
J Immunol; 2011 Jun; 186(12):6753-61. PubMed ID: 21555534
[TBL] [Abstract][Full Text] [Related]
20. Human peripheral blood DNAM-1
Stannard KA; Lemoine S; Waterhouse NJ; Vari F; Chatenoud L; Gandhi MK; Martinet L; Smyth MJ; Guillerey C
Blood Adv; 2019 Jun; 3(11):1681-1694. PubMed ID: 31167820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
